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ABSTRACT  
 
Recombinant protein production is a useful technology 
for therapeutic and diagnostic applications. The 
bacterium Escherichia coli is widely used for the bio-
production of proteins, but still presents some drawbacks. 
Recombinant proteins with biomedical interest have 
proved difficult to express properly in this host system, 
resulting in insoluble protein aggregates. Fusion protein 
technology has been applied to overcome these 
drawbacks and to optimize protein expression in E. coli. 
This research aims at the evaluation of a novel fusion 
system (Fh8 and H tags) effects on protein production. 
Target proteins used in this work present biomedical 
interest and results obtained here showed that these novel 
fusion tags increased protein production yields. This 
novel fusion system is a promising tool for the 
production of recombinant proteins with biomedical 
interest.  
 
 
INTRODUCTION 
 
Recombinant protein production had become a valuable 
technology for the development of biomedical solutions. 
A range of host cells and expression systems have been 
used for recombinant protein expression, including 
Escherichia coli – the main widely used factory for bio-
production of proteins. In spite of offering a rapid and 
low cost production of the desired protein, many proteins 
of biomedical interest have proved difficult to express 
properly in this host system, resulting in insoluble and 
instable protein aggregates, known as inclusion bodies 
(Jana and Deb 2005; Terpe 2006). Fusion protein 
technology has been applied to optimize protein 
expression in E. coli. The ideal fusion partner/tag should 
increase target protein production yields, promote its 
solubility and help on its purification (Waugh 2005; 
Esposito and Chatterjee 2006). Several fusion partners 
had already been described in literature; most of them are 
well employed in laboratories around the world. Until 
now, however, none of these fusion systems provided 
an efficient and universally effect on target protein 
production, bringing with it a new set of opportunities 
for improvement. A novel fusion system with the 
potential for soluble protein overexpression in E. coli 
was recently discovered (Castro, et al. 2009). This 
system consists of two new fusion partners: Fh8 and H 
tags, which are characterized by their low molecular 
weight (8 kDa and 1 kDa, respectively) and their ability 
to improve the production of difficult-to-express 
proteins. Taking into account the potentialities 
mentioned above, this research aims at the evaluation 
of the novel fusion tags effects on recombinant protein 
production in E. coli. First, it is intended to explore the 
application of Fh8 and H molecules as novel fusion 
partners and latter, to discover the mechanisms behind 
the stability and solubilisation actions potentially 
conferred by the new fusion partners. Different target 
recombinant proteins with biomedical applications are 
being used to complete the first goal. These target 
proteins were previously produced in E. coli but 
remained difficult-to-express on this host cell, 
presenting low production yields. This work reports the 
effect of the novel fusion partners on production yields 
of Toxoplasma gondii oocyst wall protein (TgOWP) 
and Entamoeba histolytica cyst wall protein (ENT).  
Both recombinant proteins present a diagnostic and 
therapeutic potential.  
   
 
METHODS 
 
Fusion DNA construction 
Target protein codifying sequences were amplified 
from genomic DNA by PCR, using specific primers to 
introduce the recognition sites for restriction enzyme 
cleavage. PCR products were cloned into pGEM T-
easy vector (Promega) and used to transform E. coli 
XL1 strain. Positive clones were selected and digested 
with specific restriction enzymes to be inserted next 
into fusion vectors containing Fh8 or H tags. E. coli 
M15 [pREP4] cells were then transformed with the 
resulting fusion vectors and used for fusion protein 
expression.  
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Fusion proteins production 
E. coli cells were grown at 37 ºC in LB medium 
supplemented with specific antibiotics. When the 
O.D.600nm reached 0.5, cells were induced with 1 mM of 
IPTG for 5 hours at 37 ºC for the expression of 
recombinant fusion proteins. Cells were then harvested 
by centrifugation and the resulting pellets were lysed 
overnight with 8M urea.  After cell extracts 
centrifugation, fusion protein soluble fraction was 
purified by nickel affinity. The produced fusion proteins 
were analysed by SDS-PAGE and quantified by Bradford 
assay. 
 
 
RESULTS 
 
In order to access the effect of Fh8 and H novel fusion 
tags on target proteins production, a comparative study 
was conducted between non-fused proteins and fusion 
proteins with Fh8 and/or H tags.  
 
 
When fused to H-tag, TgOWP recombinant protein was 
successfully produced in E. coli. The fusion of H tag 
promoted a production yield 6-folds higher than the 
obtained for non-fused protein (Figure 1.a). SDS-PAGE 
analysis confirmed the production of both TgOWP (13 
kDa) and H-TgOWP (14 kDa) proteins at the expected 
molecular weight (Figure 1.b).   
 
Figure 1. Production yields obtained for TgOWP and H-
TgOWP recombinant proteins (a) and proteins SDS-
PAGE analysis (b).  
 
A similar effect was observed for ENT recombinant 
protein. The addition of both Fh8 and H tags resulted in a 
production yield 3-folds higher than the obtained for non-
fused ENT protein (Figure 2.a). SDS-PAGE analysis 
showed that non-fused (7 kDa) and fused ENT (H-fused 
8 kDa; Fh8-fused 15 kDa) proteins were produced at the 
expected molecular weights (Figure 2.b). 
 
 
 
 
 
Figure 2. Production yields obtained for ENT and H-
ENT recombinant proteins (a) and proteins SDS-PAGE 
analysis (b).  
 
CONCLUSIONS 
 
This work is still in progress. Results presented here 
demonstrated that both novel fusion partners - Fh8 and 
H tags - promoted an increase of protein production 
yields in E. coli, making them promising tools for the 
production of recombinant proteins with biomedical 
interest. Nevertheless, we have new goals: to access the 
effect of novel fusion tags on target protein biological 
activities, to improve purification methodologies and 
finally, to understand the mechanisms behind the 
overproduction effect inside the host cell.  
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